PHASE-II TRIAL OF FLUTAMIDE IN HYPER-NEPHROMA CORRELATION WITH HORMONE RECEPTOR-SITES

被引：0
|
作者：
BENEDETTO, P
YAGODA, A
WATSON, RC
SOGANI, P
NERI, RO
PERTSCHUK, LP
FISHMAN, J
BRADLOW, JL
机构：
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
[2] ROCKEFELLER UNIV,NEW YORK,NY 10021
[3] SUNY DOWNSTATE MED CTR,BROOKLYN,NY 11203
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：466 / 466
页数：1
相关论文
共 50 条
  • [21] PHASE-II EVALUATION OF MITOGUAZONE IN METASTATIC HORMONE-RESISTANT PROSTATE-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
    MOORE, MR
    GRAHAM, SD
    BIRCH, R
    IRWIN, L
    CANCER TREATMENT REPORTS, 1987, 71 (01): : 89 - 90
  • [22] ADVANCED PROSTATIC-CANCER - A PHASE-II TRIAL OF THE GONADOTROPIN-RELEASING-HORMONE ANALOG (GNRHA) BUSERELIN GIVEN BY NASAL SPRAY
    VOROBIOF, DA
    FALKSON, G
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 69 - 69
  • [23] ADVANCED PROSTATIC-CANCER - A PHASE-II TRIAL OF THE GONADOTROPIN-RELEASING-HORMONE ANALOG (GNRHA) BUSERELIN GIVEN BY NASAL SPRAY
    FALKSON, G
    VOROBIOF, DA
    FALKSON, HC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 177 - 177
  • [24] PHASE-II EVALUATION OF WEEKLY CISPLATIN IN METASTATIC HORMONE-RESISTANT PROSTATE-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
    MOORE, MR
    TRONER, MB
    DESIMONE, P
    BIRCH, R
    IRWIN, L
    CANCER TREATMENT REPORTS, 1986, 70 (04): : 541 - 542
  • [25] PHASE-II TRIAL OF 5-FLUOROURACIL AND ALPHA-2B INTERFERON IN PATIENTS WITH HORMONE-REFRACTORY METASTATIC PROSTATE-CANCER
    DREICER, R
    FOREST, PK
    WILLIAMS, RD
    UROLOGY, 1994, 44 (03) : 377 - 380
  • [26] Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer
    Yuan, Yuan
    Lee, Jin Sun
    Yost, Susan E.
    Frankel, Paul H.
    Ruel, Christopher
    Egelston, Colt A.
    Guo, Weihua
    Padam, Simran
    Tang, Aileen
    Martinez, Norma
    Schmolze, Daniel
    Presant, Cary
    Ebrahimi, Behnam
    Yeon, Christina
    Sedrak, Mina
    Patel, Niki
    Portnow, Jana
    Lee, Peter
    Mortimer, Joanne
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 11 - 20
  • [27] Results from the phase lb/II clinical trial of bazedoxifene and palbociclib in hormone receptor positive metastatic breast cancer
    Jeselsohn, R.
    Guo, H.
    Rees, R.
    Barry, W. T.
    Barlett, C. H.
    Tung, N. M.
    Krop, I. E.
    Brown, M.
    Winer, E. P.
    CANCER RESEARCH, 2019, 79 (04)
  • [28] A Phase II trial of letrozole in combination with bevacizumab in patients with hormone receptor-positive metastatic breast cancer: Correlation of response with circulating endothelial (CEC) and epithelial cells (CTC)
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 163 - 164
  • [29] A PHASE-II TRIAL OF CARBOPLATIN (CBDCA) IN SMALL-CELL AND NON-SMALL-CELL LUNG-CANCER WITH CORRELATION TO INVITRO ANALYSIS OF CYTOTOXICITY
    DMITROVSKY, E
    SEIFTER, EJ
    GAZDAR, AF
    TSAI, CM
    EDISON, M
    BRANTLEY, P
    VEACH, SR
    BATIST, G
    IHDE, DC
    MULSHINE, JL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (04): : 285 - 289
  • [30] OATH trial: A phase II clinical trial evaluating the combination of onapristone with anastrozole for women with hormone receptor positive endometrial cancer-Preliminary results
    Schilder, Russell J.
    Shahin, Mark S.
    Edelson, Mitchell
    Rosenblum, Norman G.
    Douglas, Ashley
    Bhattacharya, Saveri
    Sahmoud, Tarek
    Burton, Elizabeth
    Bhatia, Avnish K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345